Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Beasley (Wellington, New Zealand). The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?. Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 What is a phenotype and how to define clinical phenotypes of obstructive airway disease Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Distinct clinical phenotypes of airways disease defined by cluster analysis Source: Eur Respir J 2009; 34: 812-818 Year: 2009 Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015 NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021 Year: 2021 Mucosal cryobiopsies: A novel method for studying obstructive airways disease? Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 New possibilities for modifying the course of chronic obstructive pulmonary disease: the effect of tiotropium bromide on certain pathogenetic links of neocollagenogenesis of the bronchial tree Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Clinical relevance of airway remodelling in airway diseases Source: Eur Respir J 2007; 30: 134-155 Year: 2007 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Defining severe obstructive lung disease in the biologic era: an endotype-based approach Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019 Year: 2019 Non-invasive sanitation of a bronchial tree with different phenotypes of chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Understanding the different physiology behind breathlessness due to obstructive and restrictive lung diseases Source: Annual Congress 2009 - PG10 Self management in chronic respiratory disease Year: 2009 The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001